On February 3, 2020, Cohen Mizrahi resigned as a director and as an officer of Bionovate Technologies Corp. Dr. Mizrahi's resignation was not the result of a disagreement between Dr. Mizrahi and company on any matter relating to company's operations, policies or practices. On February 3, 2020, David Magana Gonzalez was appointed as a director to replace Dr. Mizrahi and he was also appointed President, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer of company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% |
|
0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 775 | |
+81.31% | 5.85B | |
+94.72% | 1.25B | |
+2.57% | 986M | |
+29.44% | 855M | |
+2.30% | 666M | |
+1.44% | 604M | |
-.--% | 600M | |
+10.28% | 536M | |
-.--% | 500M |
- Stock Market
- Equities
- BIIO Stock
- News Bionovate Technologies Corp
- Bionovate Technologies Corp. Announces Management Changes